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Poor development Background: Perturbations of the infant gut microbiota can shape development of the immune system and link to the risk of allergic diseases. Objective: We sought to understand the role of the gut microbiome in patients with atopic dermatitis (AD). The metagenome of the infant gut microbiome was analyzed according to feeding types. Methods: Composition of the gut microbiota was analyzed in fecal samples from 129 infants (6 months old) by using pyrosequencing, including 66 healthy infants and 63 infants with AD. The functional profile of the gut microbiome was analyzed by means of whole-metagenome sequencing (20 control subjects and 20 patients with AD). In addition, the total number of bacteria in the feces was determined by using realtime PCR.
Results: The gut microbiome of 6-month-old infants was different based on feeding types, and 2 microbiota groups (Bifidobacterium species-dominated and Escherichia/Veillonella species-dominated groups) were found in breast-fed and mixed-fed infants. Bacterial cell amounts in the feces were lower in infants with AD than in control infants. Although no specific taxa directly correlated with AD in 16S rRNA gene results, whole-metagenome analysis revealed differences in functional genes related to immune development. The reduction in genes for oxidative phosphorylation, phosphatidylinositol 3-kinaseAkt signaling, estrogen signaling, nucleotide-binding domainlike receptor signaling, and antigen processing and presentation induced by reduced colonization of mucin-degrading bacteria (Akkermansia muciniphila, Ruminococcus gnavus, and Lachnospiraceae bacterium 2_1_58FAA) was significantly associated with stunted immune development in the AD group compared with the control group (P < .05). Conclusions: Alterations in the gut microbiome can be associated with AD because of different bacterial genes that can modulate host immune cell function. (J Allergy Clin Immunol 2018;141:1310-9.)
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The gut microbiome affects many aspects of human health, including metabolism, gastrointestinal health, and the immune response. 1 Infancy is a critical period for colonization of the gut microbiota, which affects host immune development. Colonization of the gut microbiota in infancy is influenced by many factors, including host genotype, mode of delivery, feeding type, and antibiotic/probiotic treatments. [2] [3] [4] In particular, feeding type effectively regulates the diversity and composition of the gut microbiota in infancy, and disturbances of the gut microbiome in early life have been linked to several noncommunicable diseases, such as obesity, cardiovascular disease, and allergic disease. 5 Atopic dermatitis (AD) is a common, chronic, pruritic inflammatory skin disease associated with cutaneous hyperactivity to environmental triggers, and it can affect at least 15% of children. 6, 7 Although usually AD presents during infancy and early childhood, it can persist into adolescence and adulthood. 8 Despite various clinical and experimental studies of AD, the cause of this disease remains unclear. Several studies have shown that the microbiota of infants with AD differs from that of infants without AD. [9] [10] [11] Temporal associations of the microbiota with multisensitized atopy, IgE-associated eczema, and asthma development have been studied. 9, [12] [13] [14] Because the microbiota is linked to immune development and immune responses, it is reasonable to speculate that the microbiome can play an important role in development of allergic diseases. 2, 13, [15] [16] [17] Although differences in the gut microbiota precede the manifestation of allergic disease, causes of the differences in gut microbiota between healthy infants and infants with allergic disease have been difficult to determine because of a number of confounding factors that affect gut microbiome colonization. 12, 14, 18, 19 Feeding type has the greatest influence on colonization of the gut microbiome in early life and can affect the development of AD. 20 However, studies on the complex relationship between the gut microbiome and AD according to feeding type in early life are lacking. In addition, wholemetagenome sequencing provides a higher resolution of taxonomic profile with functional classification of the microbiome than does 16S rRNA gene sequencing; however, application of this technique remains rare in gut microbiome studies of infants with AD. 17, 21 In the present study we compared the composition of the gut microbiota between healthy 6-month-old infants and infants with AD according to feeding type. Furthermore, functional differences in the gut microbiome between healthy infants and infants with AD were analyzed to understand the role of the gut microbiome in patients with AD in early life.
METHODS

Study subjects and sampling
Study subjects consisted of 129 six-month-old infants (66 healthy control subjects and 63 infants with AD) from the longitudinal Cohort for Childhood Origin of Asthma and Allergic Diseases (COCOA) birth cohort study. 22 AD in infants was diagnosed by a pediatric allergist according to Hanifin and Rajka criteria 23 at 6 and 12 months of age, and the severity of physical symptoms was assessed by using the SCORAD index at 6 months. Measurement of levels of total IgE and egg-and milk-specific serum IgE at 12 months of age was performed with a fluorescent enzyme immunoassay (ImmunoCAP; Phadia AB, Uppsala, Sweden) on all subjects. Atopy was defined as the presence of specific IgE for eggs or milk. For microbiota analysis, subjects were selected by using propensity score matching to contrast the microbiota profiles of AD samples and control samples with similar propensities for atopic disease. 24, 25 The characteristics used to determine the propensity scores are shown in Table I . Broad-spectrum antibiotics were not prescribed after birth in our study population. Fecal samples were collected and immediately stored at 2808C before being processed for DNA extraction. Details are provided in the Methods section in this article's Online Repository at www.jacionline.org.
Metagenomic DNA extraction and pyrosequencing
Metagenomic DNA was extracted from 250 mg of feces by using the Power Microbiome RNA/DNA Isolation Kit (Mo Bio/Qiagen, Carlsbad, Calif), according to the manufacturer's instructions. The extracted DNA was quantified on a BioPhotometer D30 with a mCuvette G1.0 (Eppendorf, Hamburg, Germany) and stored at 2808C until further processing.
For pyrosequencing, extracted DNA was amplified by using barcoded primers targeting the V1-V3 region of the 16S rRNA gene. Preparation for sequencing is detailed in the Methods section in this article's Online Repository. Sequencing was performed on a Roche/454 FLX Titanium system (Roche, Mannheim, Germany), according to the manufacturer's instructions.
Pyrosequencing analysis
Pyrosequencing reads were analyzed, as described previously. 26 For enterotype clustering of gut microbiota, the Jensen-Shannon divergence and other distance metrics for the relative abundance of genera were calculated. 27, 28 Details of the analysis process are provided in the Methods section in this article's Online Repository.
Whole-metagenome sequencing and analysis
A total of 40 samples were randomly selected from each group (20 control and 20 AD samples) according to feeding type and used for wholemetagenome sequencing. Metagenomic DNA of selected samples was fragmented by using a Covaris M220 sonicator (Covaris, Woburn, Mass), and metagenomic libraries were prepared by using a TruSeq DNA sample preparation kit (Illumina, San Diego, Calif), according to the manufacturer's instructions. Sequencing was performed with the Illumina HiSeq 2500 system (250-bp paired ends). Further details of whole-metagenome sequencing and analysis are provided in the Methods section in this article's Online Repository.
Statistical analysis
Relative risk (RR) ratios and corresponding 95% CIs were calculated by using log-binominal regression with the maximum likelihood estimation in R software. Significantly different bacterial taxa and KEGG orthology categories between groups were determined by using the Kruskal-Wallis rank sum test in R software. Detailed analyses are provided in the Methods section in this article's Online Repository.
RESULTS
Comparison of diversity and composition of the gut microbiome between control subjects and infants with AD A total of 1,423,835 high-quality reads (719,168 reads with 436.1 6 14.9 bp for control samples and 704,667 reads with 429.6 6 23.6 bp for AD samples) were analyzed from fecal samples of 129 selected infants by using propensity score matching. Diversity indices of the gut microbiota were compared following normalized read numbers in each sample (see Table E1 in this article's Online Repository at www.jacionline.org). Numbers of observed operational taxonomic units (OTUs), clusters in PCoA plot, and Shannon diversity indices were not significantly different between control and AD samples (P > .05; see Figs E1 and E2 in this article's Online Repository at www. jacionline.org). However, numbers of bacterial cells in feces were significantly greater in control than AD samples (P < .01). Actinobacteria was the predominant phylum in 6-month-old infant gut microbiota collected from both healthy subjects (45.35% 6 3.71%) and infants with AD (43.69% 6 3.45%). At the genus level, 7 genera were predominant in samples from both control subjects and infants with AD. However, the prevalence of these genera was not significantly different between groups (P > .05).
Influence of feeding type on gut microbiota of 6-month-old infants
Because feeding type is a major determinant of gut microbiota colonization in 6-month-old infants, samples were analyzed according to each infant's feeding type (breast milk, formula, or mixed). Within patients with AD, the highest number of observed OTUs was found in samples from formula-fed infants (278.0 6 33.8), whereas the lowest number of observed OTUs was found in samples from breast-fed infants (215.0 6 13.7, P < .05; Fig 1) . Within healthy infants, the highest number of observed OTUs in the gut microbiota was found in mixed-fed infants (263.0 6 82.2), and the lowest number of observed OTUs was found in breast-fed infants (222.0 6 78.9, P < .01). Bacterial cell counts in fecal samples were greater in breast-fed and mixedfed control subject than in infants with AD (P <.05; Fig 1, C) . The highest amounts were detected in mixed-fed control subjects (10.36 6 0.10 log 10 cells/g), and the lowest amounts were detected in breast-fed infants with AD (9.51 6 0.14 log 10 cells/g). Bacterial counts differed according to feeding type more highly in the AD group than in the control group.
Phylum compositions of the gut microbiota were compared between control subjects and infants with AD according to feeding type (Fig 1, D-F) . The relative abundance of Actinobacteria was higher in breast-fed infants in both the control (59.31% 6 6.29%) and AD (54.26% 6 5.44%) groups. The lowest relative abundance of Actinobacteria was found in mixed-fed control subjects (35.74% 6 4.69%) and infants with AD (35.15% 6 4.45%). However, the relative abundance of Proteobacteria was greater in the gut microbiota of mixed-fed infants (31.96% 6 4.68% in control subjects and 27.38% 6 3.12% in infants with AD) than infants with in other feeding types. Differences in the relative abundances of Proteobacteria, Firmicutes, and Bacteroidetes between control subjects and infants with AD were similar in mixed-and formula-fed infants. Although there were differences in the phylum composition of the gut microbiota according to feeding type, the differences between control infants and infants with AD within the same feeding groups were not significant (P > .05). At the genus level, 6 genera were common in all feeding types (see Fig E3 in this article' s Online Repository at www.jacionline. org). Bifidobacterium was the predominant genus in both control subjects and infants with AD in all feeding groups. However, there was no significant difference in genus composition between control subjects and infants with AD (P > .05).
Different gut microbiota within the same feeding type
Enterotype clustering was performed to detail differences in the microbiota within each feeding type. Formula-fed subjects were excluded from this analysis because of the limited number of subjects (healthy subjects, n 5 7; patients with AD, n 5 6). The gut microbiota of breast-fed infants clustered into 2 enterotypes, which were driven mainly by the relative abundance of Bifidobacterium and Veillonella species at the genus level (P <.05; Fig 2, A) . The relative abundance of Bifidobacterium species was greater in breast-fed gut microbiota (BFGM) 1 (74.8% 6 19.4%) than in BFGM2 (27.22% 6 0.04%), whereas the relative abundance of Veillonella species was greater in BFGM2 (13.27% 6 3.12%) than in BFGM1 (0.87% 6 0.33%). There were also differences in Staphylococcus, Enterobacter, Klebsiella, and Raoultella species between BFGM1 and BFGM2 (P < .05; see Fig E4 in this article's Online Repository at www.jacionline.org).
The gut microbiota of mixed-fed infants also clustered into 2 enterotypes, which were driven mainly by the relative abundance of Bifidobacterium and Escherichia/Veillonella at the genus level (P <.05; Fig 2, B) . The relative abundance of Bifidobacterium species was greater in mixed-fed gut microbiota (MFGM) type 1 (46.68% 6 3.73%) than in MFGM2 (12.76% 6 1.88%), whereas the abundance of Escherichia and Veillonella species was greater in MFGM2 (33.08% 6 4.64% and 16.17% 6 3.53%, respectively) than in MFGM1 (16.67% 6 2.49% and 3.34% 6 2.49%). There were also differences in Staphylococcus, Blautia, and Clostridium species between MFGM1 and MFGM2 (see Fig E5 in this article' s Online Repository at www.jacionline. org). Although the gut microbiota of breast-fed and mixed-fed infants was clustered according to their composition, numbers of control subjects and infants with AD were similar within each cluster.
Characteristics of subjects were compared between enterotypes within each feeding group (Table II) . Vaginal delivery was preferentially associated with an MFGM1 enterotype compared with MFGM2 (P 5.03). However, there were no significant differences between enterotypes with respect to the other A, The number of observed OTUs was compared after normalized read numbers for each sample. B, Shannon diversity indices were compared among groups. C, Numbers of bacterial cells in feces were compared among groups. Cell numbers were calculated based on measurement of 16S rRNA gene copies, as described in the Methods section. D-F, Phylum composition was compared between the control and AD groups in breast milk-fed infants (Fig 1, D) , mixed milk-fed infants (Fig 1, E) , and formula milk-fed infants (Fig 1, F) . *P < .1, **P < .05, and ***P < .01.
factors analyzed. In addition, there were no significant differences in RR ratios between 2 enterotypes within the same feeding type (see Table E2 in this article's Online Repository at www. jacionline.org). Thus we analyzed functional genes of gut microbiota between control subjects and infants with AD using whole-metagenome sequencing to identify the difference in gut microbiota roles between the 2 groups.
Different functional profiles between control subjects and infants with AD determined by using whole-metagenome analysis A total of 231,010,091 reads (116.4 Gb) were analyzed after removal of human gene sequences. The dominant phyla and genera identified by the whole-metagenome analysis were similar to those identified based on 16S rRNA gene sequencing FIG 2 . Enterotype clustering of gut microbiota from 6-month-old infants. A, Two enterotypes were detected in the gut microbiota of breast milk-fed infants. Bifidobacterium was the dominant genus in BFGM1, whereas Veillonella was dominant in BFGM2. B, Two enterotypes were detected in the gut microbiota of mixed milk-fed infants. Bifidobacterium was the dominant genus in MFGM1, whereas Escherichia and Veillonella were dominant in MFGM2. In mixed-fed infants 4 pathways were significantly different between the control and AD groups (P < .05). Median numbers of genes associated with phosphatidylinositol 3-kinase (PI3K)-Akt signaling and estrogen signaling were greater in the control group than in the AD group (P 5 .0002, Fig 3) . The relative abundance of genes associated with nucleotide-binding domain (NOD)-like receptor signaling and antigen processing and presentation was also greater in control subjects than in infants with AD (P < .01, Fig 4) . The same species (Akkermansia muciniphila, Ruminococcus gnavus, and Lachnospiraceae bacterium 2_1_58FAA) contributed to differences in expression of these genes between control and AD samples (P < .05).
DISCUSSION
In this study we compared the composition of the gut microbiota between healthy infants and those with AD at 6 months of age according to feeding type. A simple comparison between control and AD samples revealed no differences in members of the gut microbiota, which might be partially due to the fact that the 6-month age point is a dynamic period of microbiota colonization in the gut. 3, 29 However, the gut microbiota differed according to feeding type, even among infants with the same disease status. The gut microbiota was divided into Bifidobacterium species-dominated microbiota and Escherichia/Veillonella species-dominated microbiota in both the breast-fed and mixed-fed groups. Nevertheless, the relative abundance of Bifidobacterium species was greater in the breast-fed compared with mixed-fed groups. Although composition of the gut microbiota in infants with AD was not significantly different from that in control subjects in 16S rRNA gene results, differences in functional metabolic genes, including genes involved in oxidative phosphorylation and NODlike receptor signaling, were found between control and AD samples within each feeding type. The relative abundances of genes associated with immune development were greater in control samples compared with AD samples. These differences were associated with the depletion of A muciniphila, R gnavus, and Lachnospiraceae bacterium 2_1_58FAA in the AD group. These findings suggest that alterations of the gut microbiota affecting host immune development might be associated with AD. In addition, our results show that the association of gut microbiota with AD should be considered feeding type and analyzed by using deep analysis of species-level identification or functional genes.
Total bacterial cell counts in fecal samples from control subjects were greater than in those from patients with AD (Fig 1, C) . The gut immune system reacts to exposure to bacterial antigens, and repeated exposure enhances development of immune responses. Therefore fewer bacteria in the gut during maturation of the immune system can result in dysfunctional immune responses. However, there were no significant differences in microbes between control subjects and infants with AD (see Fig E1) . Whether specific gut microbes are different between healthy control subjects and infants with allergic disease is a matter of debate. It was reported that Bifidobacterium, Akkermansia, and Faecalibacterium species are less abundant in the gut microbiota of infants with AD, whereas Clostridium species is more abundant. 9, 10 However, some studies found no significant differences in gut microbiota between control subjects and patients with AD, and the high abundance of Faecalibacterium prausnitzii can lead to increased risk of eczema by reducing butyrate and propionate. 17, 30 These inconsistencies could be due to differences in detection methods across studies, as well as differences in other factors affecting the gut microbiota, such as host genotype, mode of delivery, age, and feeding type. 3, 4 To reduce the effect of influencing factors on gut microbiota analysis, propensity score matching, which is an alternative technique to reduce selection bias, was used in the present study. 24, 25 No differences in these factors were found between the 2 groups (Table I ). In particular, because the age of subjects is important for accurately analyzing the difference between groups, infants with the same age were analyzed in the present study. 12, 31 Different feeding types influence the developing gut microbiota. 5, 32 Therefore the samples were analyzed according to feeding type, and differences in gut microbiota by feeding type were found within both groups (Fig 1) . Although the composition of the gut microbiota differed according to feeding type, there were no differences between control subjects and infants with AD within each feeding type (P > .05). Therefore microbiota were examined in further detail by using enterotype analysis.
The 6-month gut microbiota of breast-fed infants clustered into a Bifidobacterium species-abundant (>70% of gut microbiota) cluster (BFGM1) and a Veillonella species-abundant (>10%) cluster (BFGM2; Fig 2) . In mixed-fed infants the gut microbiota also clustered into a Bifidobacterium species-abundant (>45%) cluster (MFGM1) and an Escherichia/Veillonella speciesabundant (>29%/>12%) cluster (MFGM2). The gut microbiota of 6-month-old infants in the present study developed into either a gram-positive (Bifidobacterium species)-dominated microbiota or a gram-negative (Escherichia/Veillonella) species-dominated microbiota in both breast-fed and mixed-fed infants. Increased levels of bile acids could be associated with a gram-positive gut microbiota, whereas decreased levels of bile acids could be associated with a gram-negative gut microbiota. 33 Further studies are necessary to clarify the association of bile acids with the gut microbiome in infants.
Although differences in composition of the gut microbiota were not found between control infants and infants with AD in 16S rRNA gene results, differences in functional genes in the gut microbiota were investigated in the 2 groups. There were no differences in RR ratios and the number of patients with AD between Bifidobacterium species-dominated and Escherichia/ Veillonella species-dominated enterotypes within the same feeding type (Fig 2 and see Table E2 ). Therefore samples from each feeding type were randomly selected for whole-metagenome analysis. The relative abundance of microbial genes associated with oxidative phosphorylation was greater in control than in AD samples in breast-fed infants (see Fig E7) . Oxidative phosphorylation can be a function of the gut microbiota priming the host immune system and is associated with activation of regulatory T cells, 34 which might affect the development of AD.
In mixed-fed infants the relative abundance of genes related to PI3K-Akt, estrogen, and NOD-like receptor signaling and antigen processing and presentation was greater in the control group than in the AD group (Figs 3 and 4) . The PI3K-Akt signaling pathway is important in cell growth and survival, particularly in intestinal epithelial cells and dendritic cells, and it contributes to activation of mammalian target of rapamycin, which regulates a variety of processes, including cellular metabolism. [35] [36] [37] The mucosal immune system of the gut is also influenced by estrogen signaling in both conventional and regulatory T cells. 38 NOD-like receptors play critical roles in sensing commensal microbiota, maintaining homeostasis, and regulating intestinal inflammation. 39 To communicate with the immune system, commensal microbes, similar to pathogens, express microbially associated molecular patterns that can be sensed by specialized receptors on a variety of cells, including immune, epithelial, and endothelial cells. 40 Stimulation of the immune system by antigens from colonizing microbiota is required to promote the development of the gut immune system. 41 The lower abundance of these metabolic pathways in the AD group was associated with depletion of A muciniphila, R gnavus, and Lachnospiraceae bacterium 2_1_58FAA. These bacteria are known to degrade mucins in the gut mucus layer. 42, 43 The ability of mucin-degrading bacteria to forage on diverse and abundant glycans present in the gut mucus can have a role in early colonization by providing bacteria with an endogenous source of nutrients before the introduction of dietary glycan. 44 Depletion of A muciniphila in the gut microbiome of children with AD is reported in several studies. 9, 45 Bacteria within the Lachnospiraceae, including R gnavus, can degrade complex polysaccharides into short-chain fatty acids that can be used for energy by the host. 46 Therefore mucin-degrading bacteria provide nutrients to allow colonization of the gut by diverse microbes, and these bacteria can also influence immune development by influencing PI3K-Akt, estrogen, and NOD-like receptor signaling and antigen processing and presentation. These wholemetagenome results showed clearly the role of the infant gut microbiome in patients with AD according to feeding types with high resolution. 21 A previous study also reported the importance of accurate identification of metabolic activities by subspecies level to understand the role of the gut microbiome. 17 Therefore deep analyses, such as whole-metagenome and metatranscriptome analysis, are needed for understanding the role of the gut microbiome in the development of AD. Potential association of the colonizing gut microbiome with AD by the present study was summarized in Fig 5. Generalization of results in the present study could be difficult because of the relatively small number of samples used to generate microbiota and metagenomic data. However, the analyzed subjects were selected by using propensity score matching to reduce sampling bias. In addition, this study analyzed 129 infants at the same age and showed differences in gut microbiota according to feeding type in infants with AD by using whole-metagenome sequencing. Further studies will be necessary to clarify these findings, including the role of detected mucindegrading bacteria in infants and longitudinal changes in the gut microbiome according to alleviation or persistence of AD.
The present study suggests that analysis of gut microbiome roles by using functional gene analysis is more important than simple comparison of microbial community between control infants and infants with AD.
In conclusion, the colonization of mucin-degrading bacteria and their contribution to innate immune development in the gut plays a crucial role in infants with AD. These studies will elucidate the interaction between the gut microbiome and host immune system.
Key messages
d The gut microbiota of 6-month-old infants can be clustered into 2 enterotypes (Bifidobacterium species dominated and Escherichia/Veillonella species dominated) in both breast-fed and mixed-fed infants.
d Decreased functional genes related to host immune development in the gut microbiome were associated with AD.
d The presence of Akkermansia muciniphila, Ruminococcus gnavus, and Lachnospiraceae bacterium 2_1 58FAA was associated with alteration of functional genes related to host immune development.
